JPRN-UMIN000010518已完成未知
Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment - Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment
aga Municipal Hospital0 个研究点目标入组 30 人开始时间: 2013年4月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who falls under any of the following conditions shall be excluded: (1)diabetic coma (2)severe renal dysfunction (eGFR less than 30) (3)unstable pre or proliferative diabetic retinopathy (4)severe infection (5)administered steroid drugs (6)pregnant or planned pregnant in the near future (7)ineligible for some other medical reasons judged by the investigator
研究者
相似试验
已完成
不适用
Comparison of ultralongacting insulin, glargine and degludec in type2 diabetesType 2 diabetes mellitusJPRN-UMIN000010447Yokohama City University Medical Center70
已完成
3 期
Comparision of glargine insulin and Regular insulin on quality of perioperative glucose controlType 2 diabetes mellitus.Type 2 diabetes mellitusIRCT20141127020112N8Iran University of Medical Sciences80
进行中（未招募）
不适用
Comparative investigation of Insuline glargine versus Metformin as first line drug in treat-ment of early Type 2 Diabetes (GLORY) - GLORYDiabetes mellitus Type IIMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-006860-12-DEGWT-TUD GmbH100
招募中
不适用
Comparison of insulin glargine and insulin degludec in type 2 diabetes by continuous glucose monitoring systemtype 2 diabetesJPRN-UMIN000010715Mie Chuo Medical Center30
尚未招募
不适用
Comparison study between insulin glargine and decludec on the glucose fluctuation in Type 2 diabetic patients treated with basal insulin and oral hypoglycemic agents.JPRN-UMIN000012138Kyorin University of Medicine30